Seres Therapeutics
Latest round
- Series B
Last raised
- May 2014
Total raised
- $21M
Investors
- 4
About Seres Therapeutics
Founded in 2010 and headquartered in Massachusetts, US, Seres Therapeutics, Inc. specializes in developing live biotherapeutics. In October 2025, Seres Therapeutics, Inc. Seres Therapeutics is at the forefront of developing live biotherapeutics aimed at transforming patient health, particularly within medically vulnerable populations. Their core product offerings focus on innovative treatments designed to prevent bacterial bloodstream infections and combat antimicrobial resistance (AMR), alongside therapies for gastrointestinal (GI)-related immune diseases. These biotherapeutics leverage the company's proprietary microbiome restoration platform, which harnesses live microbes to restore balance to the gut microbiota. The company's products are targeted primarily at healthcare providers within hospitals and specialty clinics in North America and Europe, where there is a pressing need for effective treatments against resistant infections and GI disorders that significantly impact patients' quality of life. The company generates revenue through strategic partnerships and collaborations with healthcare institutions and pharmaceutical companies, combining upfront payments, milestone payments tied to research and development success, and royalties on future product sales.
Who invested in Seres Therapeutics
4 investors across 3 rounds
See all investors in Seres Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Seres Therapeutics
Who invested in Seres Therapeutics?
Seres Therapeutics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seres Therapeutics raised?
Seres Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Seres Therapeutics last raise money?
Seres Therapeutics's most recent round on record is a Series B, in May 2014.
What does Seres Therapeutics do?
Founded in 2010 and headquartered in Massachusetts, US, Seres Therapeutics, Inc.
Where is Seres Therapeutics headquartered?
Seres Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Seres Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seres Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Seres Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.